Inhibition of mannitol crystallization in frozen solutions by sodium phosphates and citrates

被引:18
作者
Izutsu, Ken-ichi [1 ]
Yomota, Chikako [1 ]
Aoyagi, Nobuo [1 ]
机构
[1] Natl Inst Hlth Sci, Setagaya Ku, Tokyo 1588501, Japan
关键词
amorphous; crystallization; formulation; freeze-drying; thermal analysis;
D O I
10.1248/cpb.55.565
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Effects of co-solutes on the physical property of mannitol and sorbitol in frozen solutions and freeze-dried solids were studied as a model of controlling component crystallinity in pharmaceutical formulations. A frozen mannitol solution (500 mm) showed a eutectic crystallization exotherm at -22.8 degrees C, whereas sorbitol remained amorphous in the freeze-concentrated fraction in the thermal scan. Various inorganic salts reduced the eutectic mannitol crystallization peak. Trisodium and tripotassium phosphates or citrates prevented the mannitol crystallization at much lower concentrations than other salts. They also raised transition temperatures of the frozen mannitol and sorbitol solutions (T-g: glass transition temperature of maximally freeze-concentrated amorphous phase). Crystallization of some salts (e.g., NaCl) induced crystallization of mannitol at above certain salt concentration ratios. Thermal and near-infrared analyses of cooled-melt amorphous sorbitol solids indicated increased intermolecular hydrogen-bonding in the presence of trisodium phosphate. The sodium phosphates and citrates should prevent crystallization of mannitol in frozen solutions and freeze-dried solids by the intense hydrogen-bonding and reduced molecular mobility in the amorphous phase.
引用
收藏
页码:565 / 570
页数:6
相关论文
共 38 条
  • [1] Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO
  • [2] 2-G
  • [3] Cannon AJ, 2000, PDA J PHARM SCI TECH, V54, P13
  • [4] Crystallization behavior of mannitol in frozen aqueous solutions
    Cavatur, RK
    Vemuri, NM
    Pyne, A
    Chrzan, Z
    Toledo-Valasquez, D
    Suryanarayanan, R
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (06) : 894 - 900
  • [5] USE OF SUBAMBIENT THERMAL-ANALYSIS TO OPTIMIZE PROTEIN LYOPHILIZATION
    CHANG, BS
    RANDALL, CS
    [J]. CRYOBIOLOGY, 1992, 29 (05) : 632 - 656
  • [6] The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems
    Craig, DQM
    Royall, PG
    Kett, VL
    Hopton, ML
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 179 (02) : 179 - 207
  • [7] LYOPHILIZATION OF PHARMACEUTICALS .I. EFFECT OF CERTAIN PHYSICAL-CHEMICAL PROPERTIES
    DELUCA, P
    LACHMAN, L
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (04) : 617 - &
  • [8] Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers
    Eriksson, JHC
    Hinrichs, WLJ
    de Jong, GJ
    Somsen, GW
    Frijlink, HW
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (09) : 1437 - 1443
  • [9] Characteristics and significance of the amorphous state in pharmaceutical systems
    Hancock, BC
    Zograf, G
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) : 1 - 12
  • [10] Effects of sodium tetraborate and boric acid on nonisothermal mannitol crystallization in frozen solutions and freeze-dried solids
    Izutsu, K
    Ocheda, SO
    Aoyagi, N
    Kojima, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 273 (1-2) : 85 - 93